Last reviewed · How we verify
Psychopharmaceuticals
Psychopharmaceuticals is a Small molecule drug developed by Marie Ociskova. It is currently in discontinued development.
Psychopharmaceuticals are chemical substances that alter psychological functioning by modulating central nervous system (CNS) activity. They affect the brain, with examples of conditions studied in clinical trials including depression, trauma, epilepsy, and pediatric cancer, and interventions such as professional support and internet-based self-administered psychological programs.
At a glance
| Generic name | Psychopharmaceuticals |
|---|---|
| Sponsor | Marie Ociskova |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- A Multiple Case Study of Schema Therapy for Difficult-to-treat Depression - DEPRE-ST*Case (NA)
- An Optimized Person Centred Intervention to Improve Quality of Life for People With Dementia Living in Care Homes. A Cluster Randomized Controlled Trial. (NA)
- Implementation and Evaluation of a Transition to Discharge Program for the Reduction of Early Readmission in a Mental Health Inpatient Unit (NA)
- Effect of Recent Alcohol, Smoking and Psychotropic Drug Use on Delirium in ICU (N/A)
- Joining Forces: Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana (Phase 4)
- Group Therapy in Primary Care for Women With Depression or Anxiety in Petropolis (Phase 3)
- Texting to Improve Adherence in HIV+ With Bipolar Disorder (NA)
- A Multicenter Randomized Controlled Trial of a Novel Family Dignity Intervention (FDI) for Asian Palliative Care (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Psychopharmaceuticals CI brief — competitive landscape report
- Psychopharmaceuticals updates RSS · CI watch RSS
- Marie Ociskova portfolio CI
Frequently asked questions about Psychopharmaceuticals
What is Psychopharmaceuticals?
Who makes Psychopharmaceuticals?
What development phase is Psychopharmaceuticals in?
Related
- Manufacturer: Marie Ociskova — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing